PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in similar to 200,000 patients (vol 24, 69, 2022)

Author(s):
Giardiello, D.; Hooning, M.J.; Hauptmann, M.; Keeman, R.; Heemskerk-Gerritsen, B.A.M.; Becher, H.; Blomqvist, C.; Bojesen, S.E.; Bolla, M.K.; Camp, N.J.; Czene, K.; Devilee, P. (0000-0002-8023-2009); Eccles, D.M.; Fasching, P.A.; Figueroa, J.D.; Flyger, H.; Garcia-Closas, M.; Haiman, C.A.; Hamann, U.; Hopper, J.L.; Jakubowska, A.; Leeuwen, F.E.; Lindblom, A.; Lubinski, J.; Margolin, S.; Martinez, M.E.; Nevanlinna, H.; Nevelsteen, I.; Pelders, S.; Pharoah, P.D.P.; Siesling, S.; Southey, M.C.; Hout, A.H. van der; Hest, L.P. van; Chang-Claude, J.; Hall, P.; Easton, D.F.; Steyerberg, E.W. (0000-0002-7787-0122); Schmidt, M.K.
Published
2022
Publication type
Other
Date issued
2022-11-22
Language
English
Publisher
BMC
hdl
1887/3564023
doi
10.1186/s13058-022-01579-z